| Year |
Citation |
Score |
| 2020 |
Gatti-Mays ME, Karzai FH, Soltani SN, Zimmer A, Green JE, Lee MJ, Trepel JB, Yuno A, Lipkowitz S, Nair J, McCoy A, Lee JM. A Phase II Single Arm Pilot Study of the CHK1 Inhibitor Prexasertib (LY2606368) in BRCA Wild-Type, Advanced Triple-Negative Breast Cancer. The Oncologist. PMID 32510664 DOI: 10.1634/Theoncologist.2020-0491 |
0.422 |
|
| 2019 |
Ignacio DN, Mason KD, Hackett-Morton EC, Albanese C, Ringer L, Wagner WD, Wang PC, Carducci MA, Kachhap SK, Paller CJ, Mendonca J, Li-Ying Chan L, Lin B, Hartle DK, Green JE, et al. Muscadine grape skin extract inhibits prostate cancer cells by inducing cell-cycle arrest, and decreasing migration through heat shock protein 40. Heliyon. 5: e01128. PMID 30705983 DOI: 10.1016/J.Heliyon.2019.E01128 |
0.459 |
|
| 2018 |
Vera-Ramirez L, Vodnala SK, Nini R, Hunter KW, Green JE. Autophagy promotes the survival of dormant breast cancer cells and metastatic tumour recurrence. Nature Communications. 9: 1944. PMID 29789598 DOI: 10.1038/S41467-018-04070-6 |
0.733 |
|
| 2018 |
Makarova AM, Frascari F, Davari P, Gorouhi F, Dutt PL, Wang L, Dhawan A, Wang GY, Green JE, Epstein EH. Ultraviolet radiation inhibits mammary carcinogenesis in an ER negative murine model by a mechanism independent of vitamin D. Cancer Prevention Research (Philadelphia, Pa.). PMID 29636351 DOI: 10.1158/1940-6207.CAPR-17-0195 |
0.323 |
|
| 2018 |
Ramirez LV, Vodnala SK, Nini R, Hunter KW, Green JE. Abstract 57: Survival of dormant breast cancer cells and metastatic tumor recurrence is dependent upon the activation of autophagy Cancer Research. 78: 57-57. DOI: 10.1158/1538-7445.Am2018-57 |
0.787 |
|
| 2017 |
Yang Y, Yang HH, Hu Y, Watson PH, Liu H, Geiger TR, Anver MR, Haines DC, Martin P, Green JE, Lee MP, Hunter KW, Wakefield LM. Immunocompetent mouse allograft models for development of therapies to target breast cancer metastasis. Oncotarget. PMID 28430642 DOI: 10.18632/oncotarget.15695 |
0.422 |
|
| 2016 |
Abu-Tayeh H, Weidenfeld K, Zhilin-Roth A, Schif-Zuck S, Thaler S, Cotarelo C, Tan TZ, Thiery JP, Green JE, Klorin G, Sabo E, Sleeman JP, Tzukerman M, Barkan D. 'Normalizing' the malignant phenotype of luminal breast cancer cells via alpha(v)beta(3)-integrin. Cell Death & Disease. 7: e2491. PMID 27906177 DOI: 10.1038/cddis.2016.387 |
0.452 |
|
| 2016 |
Min DJ, He S, Green JE. Birinapant (TL32711) Improves Responses to GEM/AZD7762 Combination Therapy in Triple-negative Breast Cancer Cell Lines. Anticancer Research. 36: 2649-57. PMID 27272773 |
0.356 |
|
| 2016 |
Aprelikova O, Tomlinson CC, Hoenerhoff M, Hixon JA, Durum SK, Qiu TH, He S, Burkett S, Liu ZY, Swanson SM, Green JE. Development and Preclinical Application of an Immunocompetent Transplant Model of Basal Breast Cancer with Lung, Liver and Brain Metastases. Plos One. 11: e0155262. PMID 27171183 DOI: 10.1371/Journal.Pone.0155262 |
0.788 |
|
| 2016 |
Aprelikova O, Chen K, El Touny LH, Brignatz-Guittard C, Han J, Qiu T, Yang HH, Lee MP, Zhu M, Green JE. The epigenetic modifier JMJD6 is amplified in mammary tumors and cooperates with c-Myc to enhance cellular transformation, tumor progression, and metastasis. Clinical Epigenetics. 8: 38. PMID 27081402 DOI: 10.1186/S13148-016-0205-6 |
0.588 |
|
| 2016 |
Park JW, Park JM, Green JE, Kim HK. Long-term effect of Wnt/β-catenin small molecule inhibitor CWP232291 on intestinal carcinogenesis in novel GEM model deficient in Smad4 and p53. Journal of Clinical Oncology. 34: 594-594. DOI: 10.1200/JCO.2016.34.4_SUPPL.594 |
0.315 |
|
| 2016 |
Ramirez LV, Bilke S, Walker R, Meltzer P, Qiu T, Rad R, Green JE. Abstract 1576: Insertional mutagenesis to identify molecular mechanisms of breast cancer dormancy and metastasis Cancer Research. 76: 1576-1576. DOI: 10.1158/1538-7445.Am2016-1576 |
0.721 |
|
| 2015 |
Thompson MD, Grubbs CJ, Bode AM, Reid JM, McGovern R, Bernard PS, Stijleman IJ, Green JE, Bennett C, Juliana MM, Moeinpour F, Steele VE, Lubet RA. Lack of effect of metformin on mammary carcinogenesis in nondiabetic rat and mouse models. Cancer Prevention Research (Philadelphia, Pa.). 8: 231-9. PMID 25681088 DOI: 10.1158/1940-6207.CAPR-14-0181-T |
0.342 |
|
| 2014 |
Geiger TR, Ha NH, Faraji F, Michael HT, Rodriguez L, Walker RC, Green JE, Simpson RM, Hunter KW. Functional analysis of prognostic gene expression network genes in metastatic breast cancer models. Plos One. 9: e111813. PMID 25368990 DOI: 10.1371/journal.pone.0111813 |
0.385 |
|
| 2014 |
El Touny LH, Vieira A, Mendoza A, Khanna C, Hoenerhoff MJ, Green JE. Combined SFK/MEK inhibition prevents metastatic outgrowth of dormant tumor cells. The Journal of Clinical Investigation. 124: 156-68. PMID 24316974 DOI: 10.1172/JCI70259 |
0.441 |
|
| 2013 |
Hu Y, Bai L, Geiger T, Goldberger N, Walker RC, Green JE, Wakefield LM, Hunter KW. Genetic background may contribute to PAM50 gene expression breast cancer subtype assignments. Plos One. 8: e72287. PMID 24015230 DOI: 10.1371/journal.pone.0072287 |
0.504 |
|
| 2013 |
Ahn SG, Dong SM, Oshima A, Kim WH, Lee HM, Lee SA, Kwon SH, Lee JH, Lee JM, Jeong J, Lee HD, Green JE. LOXL2 expression is associated with invasiveness and negatively influences survival in breast cancer patients. Breast Cancer Research and Treatment. 141: 89-99. PMID 23933800 DOI: 10.1007/S10549-013-2662-3 |
0.493 |
|
| 2013 |
Chu IM, Lai WC, Aprelikova O, El Touny LH, Kouros-Mehr H, Green JE. Expression of GATA3 in MDA-MB-231 triple-negative breast cancer cells induces a growth inhibitory response to TGFß. Plos One. 8: e61125. PMID 23577196 DOI: 10.1371/Journal.Pone.0061125 |
0.793 |
|
| 2013 |
Paolicchi E, Crea F, Farrar WL, Green JE, Danesi R. Histone lysine demethylases in breast cancer. Critical Reviews in Oncology/Hematology. 86: 97-103. PMID 23266085 DOI: 10.1016/J.Critrevonc.2012.11.008 |
0.388 |
|
| 2013 |
Touny LE, Vieira A, Mendoza A, Khanna C, Hoenerhoff M, Green J. Abstract P5-04-18: Identification of a novel combination therapy that prevents the metastatic outgrowth and reduces the viability of dormant breast cancer cells: implications for clinical translation Cancer Research. 73. DOI: 10.1158/0008-5472.Sabcs13-P5-04-18 |
0.524 |
|
| 2012 |
Switzer CH, Glynn SA, Cheng RY, Ridnour LA, Green JE, Ambs S, Wink DA. S-nitrosylation of EGFR and Src activates an oncogenic signaling network in human basal-like breast cancer. Molecular Cancer Research : McR. 10: 1203-15. PMID 22878588 DOI: 10.1158/1541-7786.Mcr-12-0124 |
0.396 |
|
| 2012 |
Bennett CN, Tomlinson CC, Michalowski AM, Chu IM, Luger D, Mittereder LR, Aprelikova O, Shou J, Piwinica-Worms H, Caplen NJ, Hollingshead MG, Green JE. Cross-species genomic and functional analyses identify a combination therapy using a CHK1 inhibitor and a ribonucleotide reductase inhibitor to treat triple-negative breast cancer. Breast Cancer Research : Bcr. 14: R109. PMID 22812567 DOI: 10.1186/Bcr3230 |
0.743 |
|
| 2012 |
Rodriguez V, Vasudevan S, Noma A, Carlson BA, Green JE, Suzuki T, Chandrasekharappa SC. Structure-function analysis of human TYW2 enzyme required for the biosynthesis of a highly modified Wybutosine (yW) base in phenylalanine-tRNA. Plos One. 7: e39297. PMID 22761755 DOI: 10.1371/Journal.Pone.0039297 |
0.345 |
|
| 2012 |
Hudson TS, Carlson BA, Hoeneroff MJ, Young HA, Sordillo L, Muller WJ, Hatfield DL, Green JE. Selenoproteins reduce susceptibility to DMBA-induced mammary carcinogenesis. Carcinogenesis. 33: 1225-30. PMID 22436612 DOI: 10.1093/Carcin/Bgs129 |
0.496 |
|
| 2012 |
Aprelikova O, Green JE. MicroRNA regulation in cancer-associated fibroblasts. Cancer Immunology, Immunotherapy : Cii. 61: 231-7. PMID 22083346 DOI: 10.1007/S00262-011-1139-7 |
0.78 |
|
| 2012 |
Chu IM, Michalowski AM, Hoenerhoff M, Szauter KM, Luger D, Sato M, Flanders K, Oshima A, Csiszar K, Green JE. GATA3 inhibits lysyl oxidase-mediated metastases of human basal triple-negative breast cancer cells. Oncogene. 31: 2017-27. PMID 21892208 DOI: 10.1038/Onc.2011.382 |
0.432 |
|
| 2011 |
O'Brien J, Hansen K, Barkan D, Green J, Schedin P, O'Brien J, Hansen K, Barkan D, Green J, Schedin P. Non-steroidal anti-inflammatory drugs target the pro-tumorigenic extracellular matrix of the postpartum mammary gland. The International Journal of Developmental Biology. 55: 745-55. PMID 22161831 DOI: 10.1387/Ijdb.113379Jo |
0.482 |
|
| 2011 |
Kim CH, Kim HK, Rettig RL, Kim J, Lee ET, Aprelikova O, Choi IJ, Munroe DJ, Green JE. miRNA signature associated with outcome of gastric cancer patients following chemotherapy. Bmc Medical Genomics. 4: 79. PMID 22112324 DOI: 10.1186/1755-8794-4-79 |
0.635 |
|
| 2011 |
Barkan D, Green JE. An in vitro system to study tumor dormancy and the switch to metastatic growth. Journal of Visualized Experiments : Jove. PMID 21860375 DOI: 10.3791/2914 |
0.457 |
|
| 2011 |
Zhu M, Yi M, Kim CH, Deng C, Li Y, Medina D, Stephens RM, Green JE. Integrated miRNA and mRNA expression profiling of mouse mammary tumor models identifies miRNA signatures associated with mammary tumor lineage. Genome Biology. 12: R77. PMID 21846369 DOI: 10.1186/Gb-2011-12-8-R77 |
0.313 |
|
| 2011 |
Murphy EA, Davis JM, Barrilleaux TL, McClellan JL, Steiner JL, Carmichael MD, Pena MM, Hebert JR, Green JE. Benefits of exercise training on breast cancer progression and inflammation in C3(1)SV40Tag mice. Cytokine. 55: 274-9. PMID 21600785 DOI: 10.1016/j.cyto.2011.04.007 |
0.347 |
|
| 2011 |
Hoenerhoff MJ, Shibata MA, Bode A, Green JE. Pathologic progression of mammary carcinomas in a C3(1)/SV40 T/t-antigen transgenic rat model of human triple-negative and Her2-positive breast cancer. Transgenic Research. 20: 247-59. PMID 20549348 DOI: 10.1007/S11248-010-9406-5 |
0.507 |
|
| 2010 |
Mendoza A, Hong SH, Osborne T, Khan MA, Campbell K, Briggs J, Eleswarapu A, Buquo L, Ren L, Hewitt SM, Dakir el H, Dakir el-H, Garfield S, Walker R, Merlino G, ... Green JE, et al. Modeling metastasis biology and therapy in real time in the mouse lung. The Journal of Clinical Investigation. 120: 2979-88. PMID 20644255 DOI: 10.1172/Jci40252 |
0.358 |
|
| 2010 |
Barkan D, El Touny LH, Michalowski AM, Smith JA, Chu I, Davis AS, Webster JD, Hoover S, Simpson RM, Gauldie J, Green JE. Metastatic growth from dormant cells induced by a col-I-enriched fibrotic environment. Cancer Research. 70: 5706-16. PMID 20570886 DOI: 10.1158/0008-5472.Can-09-2356 |
0.338 |
|
| 2010 |
Kim HK, Reyzer ML, Choi IJ, Kim CG, Kim HS, Oshima A, Chertov O, Colantonio S, Fisher RJ, Allen JL, Caprioli RM, Green JE. Gastric cancer-specific protein profile identified using endoscopic biopsy samples via MALDI mass spectrometry. Journal of Proteome Research. 9: 4123-30. PMID 20557134 DOI: 10.1021/Pr100302B |
0.364 |
|
| 2010 |
Bennett CN, Green JE. Genomic analyses as a guide to target identification and preclinical testing of mouse models of breast cancer. Toxicologic Pathology. 38: 88-95. PMID 20080934 DOI: 10.1177/0192623309357074 |
0.56 |
|
| 2009 |
Hoenerhoff MJ, Chu I, Barkan D, Liu ZY, Datta S, Dimri GP, Green JE. BMI1 cooperates with H-RAS to induce an aggressive breast cancer phenotype with brain metastases. Oncogene. 28: 3022-32. PMID 19543317 DOI: 10.1038/onc.2009.165 |
0.389 |
|
| 2009 |
Bennett C, Tomlinson C, Hollingshead M, Green J. Accelerating Combination Drug Therapies for Triple Negative Breast Cancer through Comparative Pre-Clinical Testing of Human Xenografts and a Mouse Breast Cancer Model. Cancer Research. 69: 2166-2166. DOI: 10.1158/0008-5472.Sabcs-09-2166 |
0.574 |
|
| 2008 |
Abate-Shen C, Brown PH, Colburn NH, Gerner EW, Green JE, Lipkin M, Nelson WG, Threadgill D. The untapped potential of genetically engineered mouse models in chemoprevention research: opportunities and challenges. Cancer Prevention Research (Philadelphia, Pa.). 1: 161-6. PMID 19138951 DOI: 10.1158/1940-6207.Capr-08-0076 |
0.305 |
|
| 2008 |
Bennett CN, Green JE. Unlocking the power of cross-species genomic analyses: identification of evolutionarily conserved breast cancer networks and validation of preclinical models. Breast Cancer Research : Bcr. 10: 213. PMID 18828875 DOI: 10.1186/Bcr2125 |
0.478 |
|
| 2008 |
Barkan D, Kleinman H, Simmons JL, Asmussen H, Kamaraju AK, Hoenorhoff MJ, Liu ZY, Costes SV, Cho EH, Lockett S, Khanna C, Chambers AF, Green JE. Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton. Cancer Research. 68: 6241-50. PMID 18676848 DOI: 10.1158/0008-5472.Can-07-6849 |
0.368 |
|
| 2008 |
Zhang M, Behbod F, Atkinson RL, Landis MD, Kittrell F, Edwards D, Medina D, Tsimelzon A, Hilsenbeck S, Green JE, Michalowska AM, Rosen JM. Identification of tumor-initiating cells in a p53-null mouse model of breast cancer. Cancer Research. 68: 4674-82. PMID 18559513 DOI: 10.1158/0008-5472.Can-07-6353 |
0.376 |
|
| 2008 |
Calvo A, Catena R, Noble MS, Carbott D, Gil-Bazo I, Gonzalez-Moreno O, Huh JI, Sharp R, Qiu TH, Anver MR, Merlino G, Dickson RB, Johnson MD, Green JE. Identification of VEGF-regulated genes associated with increased lung metastatic potential: functional involvement of tenascin-C in tumor growth and lung metastasis. Oncogene. 27: 5373-84. PMID 18504437 DOI: 10.1038/Onc.2008.155 |
0.544 |
|
| 2008 |
Ohta S, Lai EW, Morris JC, Pang AL, Watanabe M, Yazawa H, Zhang R, Green JE, Chan WY, Sirajuddin P, Taniguchi S, Powers JF, Tischler AS, Pacak K. Metastasis-associated gene expression profile of liver and subcutaneous lesions derived from mouse pheochromocytoma cells. Molecular Carcinogenesis. 47: 245-51. PMID 17957724 DOI: 10.1002/Mc.20388 |
0.414 |
|
| 2007 |
Shoushtari AN, Michalowska AM, Green JE. Comparing genetically engineered mouse mammary cancer models with human breast cancer by expression profiling. Breast Disease. 28: 39-51. PMID 18057542 |
0.504 |
|
| 2007 |
Datta S, Hoenerhoff MJ, Bommi P, Sainger R, Guo WJ, Dimri M, Band H, Band V, Green JE, Dimri GP. Bmi-1 cooperates with H-Ras to transform human mammary epithelial cells via dysregulation of multiple growth-regulatory pathways. Cancer Research. 67: 10286-95. PMID 17974970 DOI: 10.1158/0008-5472.Can-07-1636 |
0.365 |
|
| 2007 |
Hudson TS, Hartle DK, Hursting SD, Nunez NP, Wang TT, Young HA, Arany P, Green JE. Inhibition of prostate cancer growth by muscadine grape skin extract and resveratrol through distinct mechanisms. Cancer Research. 67: 8396-405. PMID 17804756 DOI: 10.1158/0008-5472.Can-06-4069 |
0.458 |
|
| 2007 |
Deeb KK, Michalowska AM, Yoon CY, Krummey SM, Hoenerhoff MJ, Kavanaugh C, Li MC, Demayo FJ, Linnoila I, Deng CX, Lee EY, Medina D, Shih JH, Green JE. Identification of an integrated SV40 T/t-antigen cancer signature in aggressive human breast, prostate, and lung carcinomas with poor prognosis. Cancer Research. 67: 8065-80. PMID 17804718 DOI: 10.1158/0008-5472.Can-07-1515 |
0.545 |
|
| 2007 |
Herschkowitz JI, Simin K, Weigman VJ, Mikaelian I, Usary J, Hu Z, Rasmussen KE, Jones LP, Assefnia S, Chandrasekharan S, Backlund MG, Yin Y, Khramtsov AI, Bastein R, Quackenbush J, ... ... Green JE, et al. Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Genome Biology. 8: R76. PMID 17493263 DOI: 10.1186/Gb-2007-8-5-R76 |
0.496 |
|
| 2007 |
Varticovski L, Hollingshead MG, Robles AI, Wu X, Cherry J, Munroe DJ, Lukes L, Anver MR, Carter JP, Borgel SD, Stotler H, Bonomi CA, Nunez NP, Hursting SD, Qiao W, ... ... Green JE, et al. Accelerated preclinical testing using transplanted tumors from genetically engineered mouse breast cancer models. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 2168-77. PMID 17404101 DOI: 10.1158/1078-0432.Ccr-06-0918 |
0.469 |
|
| 2007 |
Huh JI, Qiu TH, Chandramouli GV, Charles R, Wiench M, Hager GL, Catena R, Calvo A, LaVallee TM, Desprez PY, Green JE. 2-methoxyestradiol induces mammary gland differentiation through amphiregulin-epithelial growth factor receptor-mediated signaling: molecular distinctions from the mammary gland of pregnant mice. Endocrinology. 148: 1266-77. PMID 17158205 DOI: 10.1210/En.2006-0964 |
0.391 |
|
| 2007 |
Zhang X, Mehta RG, Lantvit DD, Coschigano KT, Kopchick JJ, Green JE, Hedayat S, Christov KT, Ray VH, Unterman TG, Swanson SM. Inhibition of estrogen-independent mammary carcinogenesis by disruption of growth hormone signaling. Carcinogenesis. 28: 143-50. PMID 16916863 DOI: 10.1093/Carcin/Bgl138 |
0.489 |
|
| 2007 |
Oakes SR, Robertson FG, Kench JG, Gardiner-Garden M, Wand MP, Green JE, Ormandy CJ. Loss of mammary epithelial prolactin receptor delays tumor formation by reducing cell proliferation in low-grade preinvasive lesions. Oncogene. 26: 543-53. PMID 16862169 DOI: 10.1038/Sj.Onc.1209838 |
0.447 |
|
| 2007 |
Hoenerhoff MJ, Datta S, Dimri GP, Simpson MR, Green JE. The polycomb group protein Bmi‐1 collaborates with H‐Ras to promote cellular proliferation and transformation of mammary epithelial cells in vitro, and development of poorly differentiated mammary tumors in vivo The Faseb Journal. 21. DOI: 10.1096/FASEBJ.21.5.A79 |
0.359 |
|
| 2006 |
Huh JI, Calvo A, Charles R, Green JE. Distinct tumor stage-specific inhibitory effects of 2-methoxyestradiol in a breast cancer mouse model associated with Id-1 expression. Cancer Research. 66: 3495-503. PMID 16585173 DOI: 10.1158/0008-5472.CAN-04-2372 |
0.408 |
|
| 2006 |
Varticovski L, Hollingshead MG, Anver MR, Robles AI, Green JE, Hunter KW, Merlino G, Nunez N, Hursting SD, Steeg PS, Barrett CJ. Preclinical testing using tumors from genetically engineered mouse mammary models Journal of Clinical Oncology. 24: 10067-10067. DOI: 10.1200/jco.2006.24.18_suppl.10067 |
0.414 |
|
| 2005 |
Huang S, Li Y, Chen Y, Podsypanina K, Chamorro M, Olshen AB, Desai KV, Tann A, Petersen D, Green JE, Varmus HE. Changes in gene expression during the development of mammary tumors in MMTV-Wnt-1 transgenic mice. Genome Biology. 6: R84. PMID 16207355 DOI: 10.1186/Gb-2005-6-10-R84 |
0.518 |
|
| 2005 |
Wang Z, Prins GS, Coschigano KT, Kopchick JJ, Green JE, Ray VH, Hedayat S, Christov KT, Unterman TG, Swanson SM. Disruption of growth hormone signaling retards early stages of prostate carcinogenesis in the C3(1)/T antigen mouse. Endocrinology. 146: 5188-96. PMID 16141391 DOI: 10.1210/En.2005-0607 |
0.32 |
|
| 2005 |
Green JE, Hudson T. The promise of genetically engineered mice for cancer prevention studies. Nature Reviews. Cancer. 5: 184-98. PMID 15738982 DOI: 10.1038/Nrc1565 |
0.409 |
|
| 2005 |
Gupta V, Carey JL, Kawakubo H, Muzikansky A, Green JE, Donahoe PK, MacLaughlin DT, Maheswaran S. Mullerian inhibiting substance suppresses tumor growth in the C3(1)T antigen transgenic mouse mammary carcinoma model. Proceedings of the National Academy of Sciences of the United States of America. 102: 3219-24. PMID 15728372 DOI: 10.1073/Pnas.0409709102 |
0.44 |
|
| 2005 |
Gonzalez-Moreno O, Calvo A, Joshi BH, Abasolo I, Leland P, Wang Z, Montuenga L, Puri RK, Green JE. Gene expression profiling identifies IL-13 receptor alpha 2 chain as a therapeutic target in prostate tumor cells overexpressing adrenomedullin. International Journal of Cancer. Journal International Du Cancer. 114: 870-8. PMID 15609296 DOI: 10.1002/Ijc.20789 |
0.349 |
|
| 2005 |
Huh JI, Calvo A, Stafford J, Cheung M, Kumar R, Philp D, Kleinman HK, Green JE. Inhibition of VEGF receptors significantly impairs mammary cancer growth in C3(1)/Tag transgenic mice through antiangiogenic and non-antiangiogenic mechanisms. Oncogene. 24: 790-800. PMID 15592523 DOI: 10.1038/Sj.Onc.1208221 |
0.496 |
|
| 2004 |
Ye Y, Qiu TH, Kavanaugh C, Green JE. Molecular mechanisms of breast cancer progression: lessons from mouse mammary cancer models and gene expression profiling. Breast Disease. 19: 69-82. PMID 15687699 |
0.49 |
|
| 2004 |
Kawakubo H, Carey JL, Brachtel E, Gupta V, Green JE, Walden PD, Maheswaran S. Expression of the NF-kappaB-responsive gene BTG2 is aberrantly regulated in breast cancer. Oncogene. 23: 8310-9. PMID 15378000 DOI: 10.1038/sj.onc.1208008 |
0.465 |
|
| 2004 |
Qiu TH, Chandramouli GV, Hunter KW, Alkharouf NW, Green JE, Liu ET. Global expression profiling identifies signatures of tumor virulence in MMTV-PyMT-transgenic mice: correlation to human disease. Cancer Research. 64: 5973-81. PMID 15342376 DOI: 10.1158/0008-5472.Can-04-0242 |
0.398 |
|
| 2004 |
Utomo A, Jiang X, Furuta S, Yun J, Levin DS, Wang YC, Desai KV, Green JE, Chen PL, Lee WH. Identification of a novel putative non-selenocysteine containing phospholipid hydroperoxide glutathione peroxidase (NPGPx) essential for alleviating oxidative stress generated from polyunsaturated fatty acids in breast cancer cells. The Journal of Biological Chemistry. 279: 43522-9. PMID 15294905 DOI: 10.1074/Jbc.M407141200 |
0.464 |
|
| 2004 |
Green JE, Desai KV, Ye Y, Kavanaugh C, Calvo A, Huh JI. Application of gene expression profiling for validating models of human breast cancer. Toxicologic Pathology. 32: 84-9. PMID 15209407 DOI: 10.1080/01926230490424897 |
0.481 |
|
| 2004 |
Green JE, Desai K, Ye Y, Kavanaugh C, Calvo A, Huh JI. Genomic approaches to understanding mammary tumor progression in transgenic mice and responses to therapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 385S-90S. PMID 14734496 |
0.467 |
|
| 2004 |
Come SE, Buzdar AU, Arteaga CL, Bissell MJ, Brown MA, Ellis MJ, Goss PE, Green JE, Ingle JN, Lee AV, Medina D, Nicholson RI, Santen RJ, Schiff R, Hart CS. Proceedings of the Third International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer: conference summary statement. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 327S-330S. PMID 14734487 DOI: 10.1158/1078-0432.Ccr-031213 |
0.322 |
|
| 2004 |
Moody TW, Dudek J, Zakowicz H, Walters J, Jensen RT, Petricoin E, Couldrey C, Green JE. VIP receptor antagonists inhibit mammary carcinogenesis in C3(1)SV40T antigen mice. Life Sciences. 74: 1345-57. PMID 14706566 DOI: 10.1016/J.Lfs.2003.07.043 |
0.324 |
|
| 2003 |
Fargiano AA, Desai KV, Green JE. Interrogating mouse mammary cancer models: insights from gene expression profiling. Journal of Mammary Gland Biology and Neoplasia. 8: 321-34. PMID 14973376 DOI: 10.1023/B:JOMG.0000010032.05234.6f |
0.337 |
|
| 2003 |
Wu Y, Cui K, Miyoshi K, Hennighausen L, Green JE, Setser J, LeRoith D, Yakar S. Reduced circulating insulin-like growth factor I levels delay the onset of chemically and genetically induced mammary tumors. Cancer Research. 63: 4384-8. PMID 12907608 |
0.344 |
|
| 2003 |
Kavanaugh C, Green JE. The use of genetically altered mice for breast cancer prevention studies. The Journal of Nutrition. 133: 2404S-2409S. PMID 12840216 |
0.425 |
|
| 2003 |
Best CJ, Leiva IM, Chuaqui RF, Gillespie JW, Duray PH, Murgai M, Zhao Y, Simon R, Kang JJ, Green JE, Bostwick DG, Linehan WM, Emmert-Buck MR. Molecular differentiation of high- and moderate-grade human prostate cancer by cDNA microarray analysis. Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B. 12: 63-70. PMID 12766610 DOI: 10.1097/00019606-200306000-00001 |
0.31 |
|
| 2003 |
Shibata MA, Kavanaugh C, Shibata E, Abe H, Nguyen P, Otsuki Y, Trepel JB, Green JE. Comparative effects of lovastatin on mammary and prostate oncogenesis in transgenic mouse models. Carcinogenesis. 24: 453-9. PMID 12663504 |
0.402 |
|
| 2003 |
Wakefield L, Yang Y, Dukhanina O, Tang B, Mamura M, Letterio J, Green J, Merlino G, Anver. Use of mouse models to validate and therapeutically target transforming growth factor beta as an important player in breast cancer progression. Breast Cancer Research. 5: 16-16. DOI: 10.1186/Bcr675 |
0.406 |
|
| 2002 |
Desai KV, Kavanaugh CJ, Calvo A, Green JE. Chipping away at breast cancer: insights from microarray studies of human and mouse mammary cancer. Endocrine-Related Cancer. 9: 207-20. PMID 12542399 DOI: 10.1677/Erc.0.0090207 |
0.574 |
|
| 2002 |
Green JE, Cardiff R, Hennighausen L, Wakefield L, Wagner U, Lee E, Rosen J, Medina D, Nitkin A, Liu E. Validation of transgenic mammary cancer models: goals of the NCI Mouse Models of Human Cancer Consortium and the mammary cancer CD-ROM. Transgenic Research. 11: 635-6. PMID 12509138 DOI: 10.1023/A:1021140606271 |
0.322 |
|
| 2002 |
Kavanaugh CJ, Desai KV, Calvo A, Brown PH, Couldrey C, Lubet R, Green JE. Pre-clinical applications of transgenic mouse mammary cancer models. Transgenic Research. 11: 617-33. PMID 12509137 DOI: 10.1023/A:1021159705363 |
0.528 |
|
| 2002 |
Calvo A, Xiao N, Kang J, Best CJ, Leiva I, Emmert-Buck MR, Jorcyk C, Green JE. Alterations in gene expression profiles during prostate cancer progression: functional correlations to tumorigenicity and down-regulation of selenoprotein-P in mouse and human tumors. Cancer Research. 62: 5325-35. PMID 12235003 |
0.377 |
|
| 2002 |
Calvo A, Yokoyama Y, Smith LE, Ali I, Shih SC, Feldman AL, Libutti SK, Sundaram R, Green JE. Inhibition of the mammary carcinoma angiogenic switch in C3(1)/SV40 transgenic mice by a mutated form of human endostatin. International Journal of Cancer. Journal International Du Cancer. 101: 224-34. PMID 12209972 DOI: 10.1002/Ijc.10589 |
0.439 |
|
| 2002 |
Yang YA, Dukhanina O, Tang B, Mamura M, Letterio JJ, MacGregor J, Patel SC, Khozin S, Liu ZY, Green J, Anver MR, Merlino G, Wakefield LM. Lifetime exposure to a soluble TGF-beta antagonist protects mice against metastasis without adverse side effects. The Journal of Clinical Investigation. 109: 1607-15. PMID 12070308 DOI: 10.1172/Jci15333 |
0.381 |
|
| 2002 |
Desai KV, Xiao N, Wang W, Gangi L, Greene J, Powell JI, Dickson R, Furth P, Hunter K, Kucherlapati R, Simon R, Liu ET, Green JE. Initiating oncogenic event determines gene-expression patterns of human breast cancer models. Proceedings of the National Academy of Sciences of the United States of America. 99: 6967-72. PMID 12011455 DOI: 10.1073/Pnas.102172399 |
0.425 |
|
| 2002 |
Wu K, Kim HT, Rodriquez JL, Hilsenbeck SG, Mohsin SK, Xu XC, Lamph WW, Kuhn JG, Green JE, Brown PH. Suppression of mammary tumorigenesis in transgenic mice by the RXR-selective retinoid, LGD1069 Cancer Epidemiology Biomarkers and Prevention. 11: 467-474. PMID 12010861 |
0.318 |
|
| 2002 |
Bao R, Connolly DC, Murphy M, Green J, Weinstein JK, Pisarcik DA, Hamilton TC. Activation of cancer-specific gene expression by the survivin promoter. Journal of the National Cancer Institute. 94: 522-8. PMID 11929953 DOI: 10.1093/Jnci/94.7.522 |
0.364 |
|
| 2002 |
Soares CR, Shibata MA, Green JE, Jorcyk CL. Development of PIN and prostate adenocarcinoma cell lines: a model system for multistage tumor progression. Neoplasia (New York, N.Y.). 4: 112-20. PMID 11896566 DOI: 10.1038/sj/neo/7900210 |
0.329 |
|
| 2001 |
Green JE, Shibata MA, Shibata E, Moon RC, Anver MR, Kelloff G, Lubet R. 2-difluoromethylornithine and dehydroepiandrosterone inhibit mammary tumor progression but not mammary or prostate tumor initiation in C3(1)/SV40 T/t-antigen transgenic mice. Cancer Research. 61: 7449-55. PMID 11606379 |
0.344 |
|
| 2001 |
Liu ML, Shibata MA, Von Lintig FC, Wang W, Cassenaer S, Boss GR, Green JE. Haploid loss of Ki-ras delays mammary tumor progression in C3 (1)/SV40 Tag transgenic mice. Oncogene. 20: 2044-9. PMID 11360188 DOI: 10.1038/sj.onc.1204280 |
0.326 |
|
| 2001 |
Shibata MA, Yoshidome K, Shibata E, Jorcyk CL, Green JE. Suppression of mammary carcinoma growth in vitro and in vivo by inducible expression of the Cdk inhibitor p21. Cancer Gene Therapy. 8: 23-35. PMID 11219490 DOI: 10.1038/Sj.Cgt.7700275 |
0.46 |
|
| 2001 |
Guo C, Yu S, Davis AT, Wang H, Green JE, Ahmed K. A potential role of nuclear matrix-associated protein kinase CK2 in protection against drug-induced apoptosis in cancer cells. The Journal of Biological Chemistry. 276: 5992-9. PMID 11069898 DOI: 10.1074/Jbc.M004862200 |
0.444 |
|
| 2000 |
Couldrey C, Green JE. Metastases: the glycan connection. Breast Cancer Research : Bcr. 2: 321-3. PMID 11250723 DOI: 10.1186/Bcr75 |
0.493 |
|
| 2000 |
Yoshidome K, Shibata MA, Couldrey C, Korach KS, Green JE. Estrogen promotes mammary tumor development in C3(1)/SV40 large T-antigen transgenic mice: paradoxical loss of estrogen receptoralpha expression during tumor progression. Cancer Research. 60: 6901-10. PMID 11156389 |
0.458 |
|
| 2000 |
Wu K, Kim HT, Rodriquez JL, Munoz-Medellin D, Mohsin SK, Hilsenbeck SG, Lamph WW, Gottardis MM, Shirley MA, Kuhn JG, Green JE, Brown PH. 9-cis-Retinoic acid suppresses mammary tumorigenesis in C3(1)-simian virus 40 T antigen-transgenic mice Clinical Cancer Research. 6: 3696-3704. PMID 10999763 |
0.321 |
|
| 2000 |
Green JE, Shibata MA, Yoshidome K, Liu ML, Jorcyk C, Anver MR, Wigginton J, Wiltrout R, Shibata E, Kaczmarczyk S, Wang W, Liu ZY, Calvo A, Couldrey C. The C3(1)/SV40 T-antigen transgenic mouse model of mammary cancer: ductal epithelial cell targeting with multistage progression to carcinoma. Oncogene. 19: 1020-7. PMID 10713685 DOI: 10.1038/sj.onc.1203280 |
0.417 |
|
| 1999 |
Maroulakou IG, Shibata MA, Anver M, Jorcyk CL, Liu Ml, Roche N, Roberts AB, Tsarfaty I, Reseau J, Ward J, Green JE. Heterotopic endochondrial ossification with mixed tumor formation in C3(1)/Tag transgenic mice is associated with elevated TGF-beta1 and BMP-2 expression. Oncogene. 18: 5435-47. PMID 10498897 DOI: 10.1038/sj.onc.1202926 |
0.307 |
|
| 1999 |
Yu S, Davis AT, Guo C, Green JE, Ahmed K. Differential targeting of protein kinase CK2 to the nuclear matrix upon transient overexpression of its subunits. Journal of Cellular Biochemistry. 74: 127-34. PMID 10381269 DOI: 10.1002/(Sici)1097-4644(19990701)74:1<127::Aid-Jcb14>3.0.Co;2-3 |
0.348 |
|
| 1999 |
Shibata MA, Liu ML, Knudson MC, Shibata E, Yoshidome K, Bandey T, Korsmeyer SJ, Green JE. Haploid loss of bax leads to accelerated mammary tumor development in C3(1)/SV40-TAg transgenic mice: reduction in protective apoptotic response at the preneoplastic stage. The Embo Journal. 18: 2692-701. PMID 10329616 DOI: 10.1093/Emboj/18.10.2692 |
0.44 |
|
| 1998 |
Liu ML, Von Lintig FC, Liyanage M, Shibata MA, Jorcyk CL, Ried T, Boss GR, Green JE. Amplification of Ki-ras and elevation of MAP kinase activity during mammary tumor progression in C3(1)/SV40 Tag transgenic mice. Oncogene. 17: 2403-11. PMID 9811472 DOI: 10.1038/Sj.Onc.1202456 |
0.407 |
|
| 1998 |
Green JE, Greenberg NM, Ashendel CL, Barrett JC, Boone C, Getzenberg RH, Henkin J, Matusik R, Janus TJ, Scher HI. Workgroup 3: transgenic and reconstitution models of prostate cancer. The Prostate. 36: 59-63. PMID 9650918 DOI: 10.1002/(Sici)1097-0045(19980615)36:1<59::Aid-Pros11>3.0.Co;2-H |
0.348 |
|
| 1998 |
Shibata MA, Jorcyk CL, Liu ML, Yoshidome K, Gold LG, Green JE. The C3(1)/SV40 T antigen transgenic mouse model of prostate and mammary cancer. Toxicologic Pathology. 26: 177-82. PMID 9502400 DOI: 10.1177/019262339802600121 |
0.359 |
|
| 1998 |
Shibata MA, Jorcyk CL, Devor DE, Yoshidome K, Rulong S, Resau J, Roche N, Roberts AB, Ward JM, Green JE. Altered expression of transforming growth factor betas during urethral and bulbourethral gland tumor progression in transgenic mice carrying the androgen-responsive C3(1) 5' flanking region fused to SV40 large T antigen. Carcinogenesis. 19: 195-205. PMID 9472712 DOI: 10.1093/Carcin/19.1.195 |
0.46 |
|
| 1998 |
Yoshidome K, Shibata MA, Maroulakou IG, Liu ML, Jorcyk CL, Gold LG, Welch VN, Green JE. Genetic alterations in the development of mammary and prostate cancer in the C3(1)/Tag transgenic mouse model. International Journal of Oncology. 12: 449-53. PMID 9458374 DOI: 10.3892/Ijo.12.2.449 |
0.432 |
|
| 1997 |
Green JE, Gold LL, Shibata M, Yoshidome K. Paradoxical effects of pregnancy on mammary tumor progression in C3(1)/Tag transgenic mice: correlations to human breast cancer. † 657 Pediatric Research. 41: 112-112. DOI: 10.1203/00006450-199704001-00677 |
0.398 |
|
| 1992 |
Green JE, Baird AM, Hinrichs SH, Klintworth GK, Jay G. Adrenal medullary tumors and iris proliferation in a transgenic mouse model of neurofibromatosis. The American Journal of Pathology. 140: 1401-10. PMID 1605307 |
0.302 |
|
| 1989 |
Green JE, Hinrichs SH, Vogel J, Jay G. Exocrinopathy resembling Sjögren's syndrome in HTLV-1 tax transgenic mice Nature. 341: 72-74. PMID 2788824 DOI: 10.1038/341072A0 |
0.313 |
|
| 1989 |
Green JE, Begley CG, Wagner DK, Waldmann TA, Jay G. trans activation of granulocyte-macrophage colony-stimulating factor and the interleukin-2 receptor in transgenic mice carrying the human T-lymphotropic virus type 1 tax gene. Molecular and Cellular Biology. 9: 4731-7. PMID 2689863 DOI: 10.1128/Mcb.9.11.4731 |
0.309 |
|
| Show low-probability matches. |